The benchmark dose estimation of reference levels of serum urate for gout

Clinical Rheumatology
Xiao ChenTaiyi Jin

Abstract

Hyperuricemia is the main risk factor for gout. Although the threshold of hyperuricemia has been recommended, the reference levels of serum urate for gout have not been clarified. In the present study, we estimated the reference levels of serum urate for gout. A study has shown the association between serum urate and incidence of gout during 5-15 years of follow-up. We calculated the reference levels of serum urate for gout based on the previous published data by using the benchmark dose (BMD) method. The subjects were divided into six groups according to serum urate levels (6.0, 6.5, 7.5, 8.5, 9.5, and 10 mg/dL). Gamma, LogLogistic, and LogProbit models were used in BMD calculation. If the benchmark response (BMR) was set at 5%, the 95% lower confidence bounds of BMD (BMDL) of serum urate for the total population were 8.09-8.14 mg/dL during 5 years of follow-up, 7.27-7.30 mg/dL during 10 years of follow-up, and 6.73-6.99 mg/dL during 15 years of follow-up. If the BMR was set at 1%, the BMDL further decreased by 1.4 mg/dL. They were 6.68-6.85 mg/dL, 5.97-6.03 mg/dL, and 5.25-5.36 mg/dL, respectively. Similar results were observed in men and women. A threshold of 7.0 mg/dL of serum urate may be not a sufficient goal for protecti...Continue Reading

References

Aug 1, 1991·Annals of the Rheumatic Diseases·N W McGill, P A Dieppe
Mar 1, 1972·Arthritis and Rheumatism·J N Loeb
Oct 6, 2005·Annals of Internal Medicine·Hyon K ChoiUNKNOWN American Physiological Society
Dec 3, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Salomon SandAgneta Falk Filipsson
May 25, 2007·Rheumatology·Kelsey M JordanUNKNOWN British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Gr
Feb 5, 2010·Arthritis and Rheumatism·Vidula BholeHyon Choi
Jul 16, 2011·Clinical Rheumatology·Jiunn-Horng ChenWen-Harn Pan
Jan 15, 2014·Current Opinion in Rheumatology·Thomas Bardin, Pascal Richette
Feb 27, 2014·Environmental Health Perspectives·Jessica A WignallIvan Rusyn
Dec 22, 2014·Environmental Toxicology and Pharmacology·Xiao ChenTaiyi Jin
Mar 18, 2015·Joint, Bone, Spine : Revue Du Rhumatisme·Thomas Bardin
Jul 28, 2016·Annals of the Rheumatic Diseases·P RichetteT Bardin
Mar 9, 2018·Critical Reviews in Toxicology·Lynne T HaberAlan R Boobis
Mar 17, 2018·Rheumatology·Tristan Pascart, Frédéric Lioté
May 10, 2018·Nature Reviews. Rheumatology·Tanya J MajorTony R Merriman

❮ Previous
Next ❯

Citations

Mar 23, 2018·Annals of the Rheumatic Diseases·Nicola DalbethTony R Merriman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.